메뉴 건너뛰기




Volumn 160, Issue 22, 1998, Pages 3226-3227

Drug interaction between warfarin and coenzym Q10;Interaktion mellem warfarin og coenzym Q10

Author keywords

[No Author keywords available]

Indexed keywords

UBIDECARENONE; VITAMIN K GROUP; WARFARIN;

EID: 0032565599     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (50)

References (5)
  • 1
    • 0342376278 scopus 로고
    • Oskadlighetsbedömning av coenzym Q10
    • Hallström H. Oskadlighetsbedömning av coenzym Q10. Vår Foda 1993; 45: 250-9.
    • (1993) Vår Foda , vol.45 , pp. 250-259
    • Hallström, H.1
  • 2
    • 0028104286 scopus 로고
    • Reduced effect of warfarin caused by ubidecarenone
    • Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994; 344: 1372-3.
    • (1994) Lancet , vol.344 , pp. 1372-1373
    • Spigset, O.1
  • 3
    • 7144236016 scopus 로고
    • Lund: Lægemiddelkomiteerne og Sygehusapotekerne
    • Larsson IS, ed. Medicinsk bulletin. Lund: Lægemiddelkomiteerne og Sygehusapotekerne 1995; uge 11-12.
    • (1995) Medicinsk Bulletin , pp. 11-12
    • Larsson, I.S.1
  • 4
    • 0029132010 scopus 로고
    • Kan vitamin. Q10 mindske effekten af antikoagulantia?
    • Diamant B. Kan vitamin. Q10 mindske effekten af antikoagulantia? Ugeskr Læger 1995; 157: 4954.
    • (1995) Ugeskr Læger , vol.157 , pp. 4954
    • Diamant, B.1
  • 5
    • 7144245558 scopus 로고
    • Drugs used in disorders of coagulation
    • Katzung BG, ed. East Norwalk. Appleton & Lange
    • O'Reilly RA. Drugs used in disorders of coagulation. I: Katzung BG, ed. Basic and clinical pharmacology. 4th ed. East Norwalk. Appleton & Lange, 1989: 406-18.
    • (1989) Basic and Clinical Pharmacology. 4th Ed. , pp. 406-418
    • O'Reilly, R.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.